Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1983 1
1987 1
1988 1
1989 2
1990 1
1992 3
1994 10
1995 10
1996 7
1998 3
1999 1
2000 2
2001 7
2002 5
2003 10
2005 1
2006 1
2007 1
2009 1
2010 2
2011 1
2013 2
2014 3
2015 2
2016 1
2019 1
2020 4
2021 5
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

88 results
Results by year
Filters applied: . Clear all
Page 1
Response.
Kamb A, Liu Q, Harshman K, Tavtigian S, Cordon-Cardo C, Skolnick MH. Kamb A, et al. Science. 1994 Jul 15;265(5170):416-7. doi: 10.1126/science.265.5170.416. Science. 1994. PMID: 17838044 No abstract available.
Re-examination of MAGE-A3 as a T-cell Therapeutic Target.
Martin AD, Wang X, Sandberg ML, Negri KR, Wu ML, Toledo Warshaviak D, Gabrelow GB, McElvain ME, Lee B, Daris ME, Xu H, Kamb A. Martin AD, et al. Among authors: kamb a. J Immunother. 2021 Apr 1;44(3):95-105. doi: 10.1097/CJI.0000000000000348. J Immunother. 2021. PMID: 33284140 Free PMC article.
Genetic predisposition to melanoma.
Skolnick MH, Cannon-Albright LA, Kamb A. Skolnick MH, et al. Among authors: kamb a. Eur J Cancer. 1994;30A(13):1991-5. doi: 10.1016/0959-8049(94)00392-i. Eur J Cancer. 1994. PMID: 7734213 Review. No abstract available.
Cell-cycle regulators and cancer.
Kamb A. Kamb A. Trends Genet. 1995 Apr;11(4):136-40. doi: 10.1016/s0168-9525(00)89027-7. Trends Genet. 1995. PMID: 7732591 Review.
Response.
Kamb A. Kamb A. Science. 1995 Jan 6;267(5194):16. doi: 10.1126/science.267.5194.16. Science. 1995. PMID: 17840043 No abstract available.
What's wrong with our cancer models?
Kamb A. Kamb A. Nat Rev Drug Discov. 2005 Feb;4(2):161-5. doi: 10.1038/nrd1635. Nat Rev Drug Discov. 2005. PMID: 15688078 Review.
Why is cancer drug discovery so difficult?
Kamb A, Wee S, Lengauer C. Kamb A, et al. Nat Rev Drug Discov. 2007 Feb;6(2):115-20. doi: 10.1038/nrd2155. Epub 2006 Dec 8. Nat Rev Drug Discov. 2007. PMID: 17159925 Review.
Engineered T cells directed at tumors with defined allelic loss.
Hamburger AE, DiAndreth B, Cui J, Daris ME, Munguia ML, Deshmukh K, Mock JY, Asuelime GE, Lim ED, Kreke MR, Tokatlian T, Kamb A. Hamburger AE, et al. Among authors: kamb a. Mol Immunol. 2020 Dec;128:298-310. doi: 10.1016/j.molimm.2020.09.012. Epub 2020 Oct 1. Mol Immunol. 2020. PMID: 33012527 Free article.
Cyclin-dependent kinase inhibitors and human cancer.
Kamb A. Kamb A. Curr Top Microbiol Immunol. 1998;227:139-48. doi: 10.1007/978-3-642-71941-7_7. Curr Top Microbiol Immunol. 1998. PMID: 9479829 Review. No abstract available.
88 results